Related Experiment Video
Updated: Aug 10, 2026
16:59
Neo-Islet Formation in Liver of Diabetic Mice by Helper-dependent Adenoviral Vector-Mediated Gene Transfer
Published on: October 10, 2012
Newborn liver gene transfer by an HIV-2-based lentiviral vector
B Salani1, P Damonte, A Zingone
1Laboratory of Molecular Biology, G Gaslini Institute, Genova, Italy.
Gene Therapy
|March 18, 2005
Summary
Newborn gene therapy using a lentiviral vector demonstrated efficient liver transduction in mice. Early intervention and low-dose infection show promise for targeting the newborn liver.
Area of Science:
- Gene therapy
- Viral vectors
- Neonatal research
Background:
- Gene therapy offers potential to prevent disease-related damage.
- Evaluating gene transfer in newborn tissues is crucial for therapeutic development.
Purpose of the Study:
- To assess the efficacy and safety of lentiviral vector gene transfer in newborn mice.
- To compare gene transfer efficiency in newborn versus adult mice.
Main Methods:
- Utilized a human immunodeficiency virus (HIV)-2 based lentiviral vector expressing green fluorescent protein.
- Administered low doses of the vector to newborn and adult mice.
- Analyzed gene expression and vector detection in liver tissues using molecular methods.
Main Results:
- Low doses of HIV-2 vectors efficiently infected and expressed genes in newborn mice, primarily targeting the liver.
- Transduced hepatocytes proliferated, and gene expression was stable without observed toxicity.
- Liver transduction efficiency was significantly higher in newborn mice compared to adults.
Conclusions:
- Early intervention with low-multiplicity lentiviral vector infection is a viable strategy for efficient newborn liver targeting in gene therapy.
- Neonatal gene therapy holds promise for preventing disease onset through targeted gene delivery.
